Logo image of MDCO

MEDICINES CO (MDCO) Stock Price, Forecast & Analysis

USA - NASDAQ:MDCO -

84.9
-0.06 (-0.07%)
Last: 1/3/2020, 8:00:00 PM
84.9
0 (0%)
After Hours: 1/3/2020, 8:00:00 PM

MDCO Key Statistics, Chart & Performance

Key Statistics
Market Cap6.77B
Revenue(TTM)N/A
Net Income(TTM)-236.39M
Shares79.72M
Float49.41M
52 Week High84.98
52 Week Low18.83
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-2.98
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


MDCO short term performance overview.The bars show the price performance of MDCO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

MDCO long term performance overview.The bars show the price performance of MDCO in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300

The current stock price of MDCO is 84.9 null. In the past month the price increased by 0.99%. In the past year, price increased by 356.21%.

MEDICINES CO / MDCO Daily stock chart

MDCO Latest News, Press Relases and Analysis

About MDCO

Company Profile

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.

Company Info

MEDICINES CO

8 SYLVAN WAY

PARSIPPANY NJ 07054

CEO: Mark Timney

Phone: 973-290-6000

MEDICINES CO / MDCO FAQ

Can you describe the business of MEDICINES CO?

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.


What is the stock price of MEDICINES CO today?

The current stock price of MDCO is 84.9 null. The price decreased by -0.07% in the last trading session.


What is the dividend status of MEDICINES CO?

MDCO does not pay a dividend.


What is the ChartMill technical and fundamental rating of MDCO stock?

MDCO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Should I buy MDCO stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MDCO.


MDCO Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to MDCO. When comparing the yearly performance of all stocks, MDCO is one of the better performing stocks in the market, outperforming 99.5% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MDCO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MDCO. MDCO has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MDCO Financial Highlights

Over the last trailing twelve months MDCO reported a non-GAAP Earnings per Share(EPS) of -2.98. The EPS increased by 32.27% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -26.35%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-24.32%
Sales Q2Q%100%
EPS 1Y (TTM)32.27%
Revenue 1Y (TTM)-100%

MDCO Forecast & Estimates


Analysts
Analysts68.8
Price TargetN/A
EPS Next Y-17.53%
Revenue Next YearN/A

MDCO Ownership

Ownership
Inst OwnersN/A
Ins Owners3.73%
Short Float %N/A
Short RatioN/A